Next-generation sequencing in neuromuscular diseases

Area of Science:

• Genetics
• Neurology
• Molecular Diagnostics

Background:

• Neuromuscular diseases are highly heterogeneous, with many Mendelian defects, causing significant disability and early mortality.
• Diagnosing these disorders is challenging due to large, unidentified genes and complex genetic variants, leading to diagnostic delays.
• Traditional diagnostic methods struggle with the complexity and heterogeneity of neuromuscular conditions.

Purpose of the Study:

• To review recent advances in the genetic diagnosis of neuromuscular disorders.
• To highlight the impact of next-generation sequencing (NGS) in research and clinical practice.
• To discuss collaborative initiatives integrating genomics and phenotyping for rare disease gene discovery.

Main Methods:

• Review of current literature on genetic diagnosis in neuromuscular disorders.
• Discussion of next-generation sequencing applications and advancements.
• Analysis of collaborative projects like the Genomics England genome sequencing project.

Main Results:

• NGS has significantly improved the diagnostic yield for neuromuscular disorders.
• NGS facilitates the identification of novel disease-causing genes and complex variants.
• Collaborative initiatives are accelerating the discovery of rare disease genes.

Conclusions:

• Next-generation sequencing is revolutionizing the genetic diagnosis of neuromuscular disorders.
• Integrating clinical phenotyping with genomics is crucial for rare disease gene identification.
• Ongoing advancements in sequencing technology and collaborative efforts promise further diagnostic improvements.